Primaa in the news
AI-based cancer diagnostics software
Tamtam found 13 recent articles about Primaa.
- Primaa Secures €7 Million in Funding
Primaa secured €7 million to expand its AI-based cancer diagnostic software across Europe and prepare for U.S. market entry.
- Primaa, l’intelligence artificielle qui assiste les médecins dans le diagnostic des cancers
Primaa's AI software Cleo assists pathologists in rapidly and accurately diagnosing cancers, reducing wait times and improving patient care without replacing doctors.
- Comment l’intelligence artificielle transforme le diagnostic anatomopathologique
AI is enhancing cancer diagnosis by automating tissue image analysis, with Primaa developing software to detect breast and skin cancers and recently securing funding to expand and enter the US market.
- Primaa raises €7M to accelerate product growth and international expansion
Primaa secured €7M to expand its AI-based cancer diagnostic tools across Europe and the US, enhancing product features and sales.
- Primaa raises €7M to advance AI cancer diagnostics
Primaa secured €7M to expand its AI-powered cancer diagnostic tools and accelerate European and US market growth.
- PathAI Expands Clinical Leadership - Announcing Partnerships with Mindpeak, Stratipath, and Primaa
PathAI expands its AISight Dx platform by partnering with Mindpeak, Stratipath, and Primaa to integrate their AI-based cancer diagnostic tools, enhancing digital pathology workflows.
- Gestalt and Primaa Collaborate to Revolutionize Skin Cancer Detection with AI-Powered Dermatopathology Tools
Gestalt and Primaa partnered to integrate AI-powered skin cancer diagnostic tools into Gestalt's PathFlow platform, enhancing pathologists' workflow and diagnostic accuracy.
- PRIMAA lève 5 millions d’euros et mise sur une détection ultra-ciblée des cancers
PRIMAA raised €5 million to advance its AI-based targeted cancer diagnostic tool Cleo, focusing on breast, skin, and prostate cancers.
- Primaa, la start-up qui développe des IA d'aide au diagnostic des cancers
Primaa is expanding its AI diagnostic software from breast to prostate cancer after raising €5 million in funding.
- Primaa : détection plus fine des cancers du sein et de la peau
Primaa uses AI to improve cancer diagnosis for breast and skin cancers, expanding in Europe and developing new tools for other cancers with plans for US market entry.
- Primaa met de l’IA dans le diagnostic histologique
Primaa applies AI in histological diagnostics, but the article is subscription-only.
- Certification européenne pour l’IA de diagnostic du cancer du sein de la startup parisienne Primaa
Primaa's AI software Cleo for breast cancer diagnosis received European certification, enabling faster pathology analysis and ongoing funding efforts.
- Primaa lève 2 millions d'euros pour accélérer la détection des cancers
Primaa secured 2 million euros to advance its AI software that aids anatomopathologists in diagnosing cancers, starting with breast and prostate, aiming for broader cancer detection and international expansion.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Primaa?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies